Literature DB >> 12116000

Serological examination of human herpesvirus 6 and 7 in patients with coronary artery disease.

Masaru Ihira1, Tetsushi Yoshikawa, Junichi Ishii, Masanori Nomura, Hitoshi Hishida, Masahiro Ohashi, Yoshihiko Enomoto, Sadao Suga, Keiji Iida, Yumiko Saito, Yukihiro Nishiyama, Yoshizo Asano.   

Abstract

Fifty-three (96%) of 55 patients with coronary artery stenosis were positive for serum anti-HHV-6 IgG, and 50 (91%) of these patients had anti-HHV-7 IgG. The number of cases sero-positive for HHV-6 and -7 in the 54 age matched control volunteers was 52 (96%) and 53 (98%), respectively. No statistical difference in the sero-prevalence of the viruses existed between the patients and the control group. The mean geometric titer (log10) of anti-HHV-6 IgG in both the patients and controls were the same (1.4) (P = 0.845), whereas anti-HHV-7 titers were 1.4 and 1.5, respectively (P = 0.161). Ten (18%) of the 55 patients had anti-HHV-6 IgM; eight (15%) of the 54 control volunteers were also positive (P = 0.636). Three (5%) of the 55 patients had anti-HHV-7 IgM, whereas 3 (6%) of the 54 control volunteers had detectable serum antibody (P = 0.691). Forty-seven of the 55 patients were examined by follow-up angiographic evaluation to clarify the association between viral infection and restenosis following balloon angioplasty. Fifteen of these patients developed restenosis, as determined by angiography. The mean geometric titer (log10) of anti-HHV-6 IgG were 1.3 and 1.4 in patients with restenosis and those without restenosis, respectively (P = 0.724). The mean geometric titer (log10) of anti-HHV-7 IgG in patients with restenosis was not significantly higher (1.5) than in patients without restenosis (1.3) (P = 0.099). Three (20%) of the 15 patients affected by restenosis had anti-HHV-6 IgM; five (16%) of the 32 control patients also had the antibody (P = 0.965). One (7%) of the 15 patients with restenosis and 2 (6%) of the 32 patients without restenosis had anti-HHV-7 IgM (P = 0.558). The present study demonstrates that HHV-6 and -7 reactivation is not associated with the establishment of coronary artery stenosis and restenosis following balloon angioplasty. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116000     DOI: 10.1002/jmv.10134

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  HHV-6-associated acute lymphadenitis in immunocompetent patients: a case report and review of literature.

Authors:  Yanfeng Bai; Zhaoming Wang; Ke Sun; Hongtian Yao
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

3.  Severe hepatitis with autoimmune features following a HHV-6: a case report.

Authors:  Pierfrancesco Grima; Roberto Chiavaroli; Paola Calabrese; Paolo Tundo; Piero Grima
Journal:  Cases J       Date:  2008-08-18

4.  Herpes virus seroepidemiology in the adult Swedish population.

Authors:  Jan Olsson; Eloise Kok; Rolf Adolfsson; Hugo Lövheim; Fredrik Elgh
Journal:  Immun Ageing       Date:  2017-05-10       Impact factor: 6.400

5.  Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease.

Authors:  Tsuneyuki Nakamura; Jun-Ichi Yamamura; Hitoshi Sato; Hiroaki Kakinuma; Hiroaki Takahashi
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02-12

6.  Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin.

Authors:  Marco Telford; Arcadi Navarro; Gabriel Santpere
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

Review 7.  The Presence of Human Herpesvirus 6 in the Brain in Health and Disease.

Authors:  Gabriel Santpere; Marco Telford; Pol Andrés-Benito; Arcadi Navarro; Isidre Ferrer
Journal:  Biomolecules       Date:  2020-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.